Polaris International Holdings, Inc. (OTCBB: PIHN), is a Delaware corporation with offices in Tokyo, Japan and a new office in the Denver, CO metro area in the business of supplying services for Network Infrastructure, ASP and Cloud Computing Solutions.
PIHN’s Medical Division, ProCannas, focuses on the manufacture and distribution of new, pharmaceutical grade cannabinoid based products for medicinal use, collectively called the Cannatrol line. They are perfecting two different versions of product formulations, including one containing Tetrahydrocannabinol (THC) and one without. The version containing THC will be manufactured and available only in the few states that allow THC based products to be distributed. The plants they will use for extraction of the non-THC based products are provided exclusively by their offshore (India) affiliate, and various versions of such formulations have been used effectively within the Eastern medical system for over 5000 years.
ProCannas offers its first-generation Cannatrol™ product line only through our trained participating physicians. Because of the purity and maximum strength of our formulations, they are best offered to patients under professional guidance. However, they will not require a formal prescription in the United States.
During the course of the extensive scientific research, conducted by noted universities and healthcare oriented organizations, a key repeatable finding, central to that research is that THC (Tetrahydrocannabinol) was not a significant contributor to the medicinal and bio-protective aspects of the plant extracts. Rather, it is the other substances (cannabinoids) that are significant active ingredients. THC is illegal in most states and is the ingredient causing one to get “high”. This finding opens the door for innovation and market success, and for ProCannas to legally develop, patent, protect and offer to the market a proprietary non-THC based Cannatrol™ formulation called Cannatrol DM, which is far less regulated by the Administration and FDA (Food and Drug Administration) as supplements, foods, and cosmetics.
Why Use Cannatrol™?
The primary differences between PIHN’s non-THC formulations and other non-THC products available on the American are significant. First, they have what they believe to be the only ultra-pure, pharmaceutical grade, maximum strength product available. Second, some of their formulations contain enhancing ingredients and antioxidants such as vitamin C, D3 (Cannatrol VM) and various curcuminoids (Cannatrol TL). To increase absorption, they offer a formulation with bioperine (Cannatrol AB).